已核实 DOI PubMed 相关产品: 83

Self-propelled assembly of nanoparticles with self-catalytic regulation for tumour-specific imaging and therapy

Journal 2024 · IF 14.7 · 15(1): 1-13 · 发表于 2024 年 1 月 11 日
作者: Xia Mengmeng,Wang Qiyue,Liu Yamin,Fang Chunyan,Zhang Bo,Yang Shengfei,Zhou Fu,Lin Peihua,Gu Mingzheng,Huang Canyu,Zhang Xiaojun,Li Fangyuan,Liu Hongying,Wang Guangfeng,Ling Daishun
阅读全文 在 PubMed 查看

摘要

Targeted assembly of nanoparticles in biological systems holds great promise for disease-specific imaging and therapy. However, the current manipulation of nanoparticle dynamics is primarily limited to organic pericyclic reactions, which necessitate the introduction of synthetic functional groups as bioorthogonal handles on the nanoparticles, leading to complex and laborious design processes. Here, we report the synthesis of tyrosine (Tyr)-modified peptides-capped iodine (I) doped CuS nanoparticles (CuS-I@P1 NPs) as self-catalytic building blocks that undergo self-propelled assembly inside tumour cells via Tyr-Tyr condensation reactions catalyzed by the nanoparticles themselves. Upon cellular internalization, the CuS-I@P1 NPs undergo furin-guided condensation reactions, leading to the formation of CuS-I nanoparticle assemblies through dityrosine bond. The tumour-specific furin-instructed intracellular assembly of CuS-I NPs exhibits activatable dual-modal imaging capability and enhanced photothermal effect, enabling highly efficient imaging and therapy of tumours. The robust nanoparticle self-catalysis-regulated in situ assembly, facilitated by natural handles, offers the advantages of convenient fabrication, high reaction specificity, and biocompatibility, representing a generalizable strategy for target-specific activatable biomedical imaging and therapy.

本研究中使用的阿拉丁产品

83 款产品在本文中被引用